NDA 215143 · Hikma
Succinylcholine Chloride
Succinylcholine Chloride · Intramuscular, Intravenous
DiscontinuedLast checked: Nov 20, 2026Latest source record: Nov 1, 2022 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2021
Aug 20, 2021
Approved uses
1
Original approval plus efficacy supplements
Registered trials
64
13 Phase 3, 4 recruiting
FAERS reports
2,012
1,725 serious, 234 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
1 products under this application
- SUCCINYLCHOLINE CHLORIDE · SUCCINYLCHOLINE CHLORIDE 100MG/5ML (20MG/ML) · SOLUTION, INTRAMUSCULAR, INTRAVENOUS · Discontinued · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Succinylcholine Chloride" as an intervention, any sponsor and status, largest first.
- Succinylcholine vs Rocuronium for Prehospital Emergency IntubationPivotal-lookingCompleted
Centre Hospitalier Universitaire de la RéunionAcademic, hospital or other
NCT02000674 · 1,321 participants · Start Dec 2013 · Primary completion Jul 2016
Drug: Succinylcholine : 1mg/kg; Rocuronium : 1.2 mg/kg · For: Coma; Major Trauma; Respiratory Distress and 1 more
Sites: Saint-Denis, France; Saint-Pierre, France; Bobigny, France · 17 sites in all
- Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle RelaxantPivotal-lookingCompleted
Nantes University HospitalAcademic, hospital or other
NCT03960801 · 1,150 participants · Start Oct 9, 2019 · Primary completion Apr 22, 2021
Drug: Remifentanil group; neuromuscular blockade group · For: Intra-tracheal Intubation
Sites: Angers, France; Brest, France; Grenoble, France · 13 sites in all
- Platform Adaptive Embedded Trial for Acute Respiratory Distress SyndromePivotal-lookingStatus unknown
Second Affiliated Hospital, Zhejiang University, School of MedicineAcademic, hospital or other
NCT05658692 · 1,000 participants (planned) · Start Oct 1, 2022 · Primary completion Oct 2023
Drug: glucocorticoid therapy; Thymosin Alpha and 5 more · For: Acute Respiratory Distress Syndrome
Sites: Beijing, China; Chengdu, China; Guangdong, China · 11 sites in all
- Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean SectionPivotal-lookingCompleted
Brno University HospitalAcademic, hospital or other
NCT01718236 · 500 participants · Start Sep 2012 · Primary completion Jan 2015
Drug: Rocuronium + sugammadex; Succinylcholine + Neostigmine · For: Caesarean Section; Pregnancy
Sites: Olomouc, Czechia; Brno, Czechia
- Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive CarePivotal-lookingCompleted
University Hospital, Basel, SwitzerlandAcademic, hospital or other
NCT00355368 · 420 participants · Start Aug 2006 · Primary completion Aug 2006
Drug: Succinylcholine; Rocuronium · For: Intubation
Sites: Basel, Switzerland
- Effects of Ciprofol Anesthesia on Learning and Memory Function and Antidepressant Effects of ECT in Depressive PatientsPivotal-lookingStatus unknown
First Affiliated Hospital of Chongqing Medical UniversityAcademic, hospital or other
NCT05266560 · 390 participants (planned) · Start Mar 1, 2022 · Primary completion Jul 1, 2024
Drug: ciprofol; Propofol · For: Depressive Disorder
- General Anesthesia Versus Sedation During Intra-arterial Treatment for StrokePivotal-lookingCompleted
Rennes University HospitalAcademic, hospital or other
NCT02822144 · 351 participants · Start Sep 29, 2016 · Primary completion Aug 2020
Drug: Etomidate; Succinylcholine and 3 more · For: Stroke
Sites: Brest, France; Paris, France; Rennes, France · 4 sites in all
- REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential MonitoringPivotal-lookingNot yet recruiting
Mayo ClinicAcademic, hospital or other
NCT07835295 · 316 participants (planned) · Start Sep 2026 · Primary completion Sep 2028
Drug: Low-Dose Remifentanil; High-Dose Remifentanil and 3 more · For: Airway Management; Endotracheal Intubation
Sites: Jacksonville, Florida
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective232
- hypotension177
- cardiac arrest160
- anaphylactic shock146
- drug interaction126
- anaphylactic reaction111
- renal failure99
- renal impairment99
- hyperthermia malignant98
- pain96
- maternal exposure during pregnancy91
- injury87
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 91 |
| 2005 | 29 |
| 2006 | 40 |
| 2007 | 48 |
| 2008 | 44 |
| 2009 | 54 |
| 2010 | 71 |
| 2011 | 190 |
| 2012 | 90 |
| 2013 | 27 |
| 2014 | 22 |
| 2015 | 44 |
| 2016 | 67 |
| 2017 | 93 |
| 2018 | 85 |
| 2019 | 148 |
| 2020 | 148 |
| 2021 | 125 |
| 2022 | 124 |
| 2023 | 122 |
| 2024 | 105 |
| 2025 | 159 |
| 2026 | 86 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Cerebral arterial blood flow velocity during induction of general anesthesia: rapid intravenous induction versus awake intubation.
Shibutani T, Hirota Y, Niwa H, et al. · Anesth Prog 1993 · Clinical Trial, Comparative Study
- Optimal dose of succinylcholine for laryngeal mask airway insertion: systematic review, meta-analysis and metaregression of randomised control trials.
Liao AH, Lin YC, Bai CH, et al. · BMJ Open 2017 · Meta-Analysis, Systematic Review
- Variation of serum potassium and creatinine phosphokinase levels in suxamethonium-induced muscle relaxation.
Guha A, Das BN, Sengupta S, et al. · J Indian Med Assoc 1996 · Clinical Trial, Comparative Study
- Adjustment of anaesthesia depth using bispectral index prolongs seizure duration in electroconvulsive therapy.
Nishihara F, Saito S · Anaesth Intensive Care 2004 · Clinical Trial, Comparative Study
- Outpatient general anesthesia: a comparison of a combination of midazolam plus propofol and propofol alone.
Reinhart DJ, Grum DR, Berry J, et al. · J Clin Anesth 1997 · Clinical Trial, Comparative Study
- Train-of-four fade and edrophonium antagonism of neuromuscular block by succinylcholine in man.
Lee C · Anesth Analg 1976 · Clinical Trial
Sponsor: Hikma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.